Catalyst Biosciences, Inc.
(NASDAQ : CBIO)

( )
CBIO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.95%171.301.3%$495.18m
BIIBBiogen Inc.
0.91%235.041.3%$480.36m
CELGCelgene Corporation
0.11%96.361.3%$457.23m
GILDGilead Sciences, Inc.
-0.03%66.500.9%$434.72m
ILMNIllumina, Inc.
2.08%312.833.5%$317.70m
REGNRegeneron Pharmaceuticals, Inc.
3.27%320.092.6%$298.61m
AAgilent Technologies, Inc.
-0.50%67.981.6%$207.68m
VRTXVertex Pharmaceuticals Incorporated
1.92%172.371.9%$181.17m
EXASExact Sciences Corporation
-2.10%94.9125.3%$163.66m
ALXNAlexion Pharmaceuticals, Inc.
-0.97%127.552.0%$149.64m
BMRNBioMarin Pharmaceutical Inc.
0.25%87.694.3%$118.55m
SRPTSarepta Therapeutics, Inc.
0.36%121.6214.7%$112.14m
INCYIncyte Corporation
0.43%79.022.5%$105.72m
IONSIonis Pharmaceuticals, Inc.
-0.98%68.568.2%$98.74m
ALNYAlnylam Pharmaceuticals, Inc
-0.09%67.819.2%$94.94m

Company Profile

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel medicines to address serious medical conditions. Its pipeline includes hemostasis such as Factor VIIa marzeptacog alfa, Factor IX dalcinonacog alfa, and Factor Xa; and anti-complement. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.